Search details
1.
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Lancet
; 399(10319): 36-49, 2022 01 01.
Article
in English
| MEDLINE | ID: mdl-34883053
2.
Sustained Declines in Age Group-Specific Rotavirus Infection and Acute Gastroenteritis in Vaccinated and Unvaccinated Individuals During the 5 Years Since Rotavirus Vaccine Introduction in England.
Clin Infect Dis
; 74(3): 437-445, 2022 02 11.
Article
in English
| MEDLINE | ID: mdl-34043765
3.
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Lancet
; 398(10303): 856-869, 2021 09 04.
Article
in English
| MEDLINE | ID: mdl-34370971
4.
Seasonal Influenza Vaccination During Pregnancy and the Risk of Major Congenital Malformations in Live-born Infants: A 2010-2016 Historical Cohort Study.
Clin Infect Dis
; 73(11): e4296-e4304, 2021 12 06.
Article
in English
| MEDLINE | ID: mdl-32572453
5.
Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK.
Emerg Infect Dis
; 27(7): 1795-1801, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34152947
6.
Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma.
J Allergy Clin Immunol
; 145(4): 1157-1164.e6, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31863808
7.
Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016.
Emerg Infect Dis
; 25(9): 1708-1718, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31441745
8.
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.
N Engl J Med
; 385(8): 759-760, 2021 08 19.
Article
in English
| MEDLINE | ID: mdl-34161702
9.
Do delays in data availability limit the implementation of near real-time vaccine safety surveillance using the Clinical Practice Research Datalink?
Pharmacoepidemiol Drug Saf
; 27(1): 25-29, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29193554
10.
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study.
Lancet
; 388(10061): 2775-2782, 2016 12 03.
Article
in English
| MEDLINE | ID: mdl-28100432
11.
Assessing recording delays in general practice records to inform near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD).
Pharmacoepidemiol Drug Saf
; 26(4): 437-445, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-28156036
12.
Near real-time vaccine safety surveillance using electronic health records-a systematic review of the application of statistical methods.
Pharmacoepidemiol Drug Saf
; 25(3): 225-37, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26817940
13.
Safety of live attenuated influenza vaccine in atopic children with egg allergy.
J Allergy Clin Immunol
; 136(2): 376-81, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25684279
14.
Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
Clin Infect Dis
; 61(11): 1637-44, 2015 Dec 01.
Article
in English
| MEDLINE | ID: mdl-26374816
15.
Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales.
Clin Infect Dis
; 58(4): 517-25, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24300040
16.
Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year later.
Clin Infect Dis
; 58(2): 181-7, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24149079
17.
Erratum to "Risk of cardiac arrhythmia and cardiac arrest after primary and booster COVID-19 vaccination in England: A self-controlled case series analysis" [Vaccine: X 15 (2023) 100418].
Vaccine X
; 16: 100449, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38322609
18.
Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study.
Lancet Infect Dis
; 24(5): 546-556, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38310905
19.
Influenza vaccination during the 2021/22 season: A data-linkage test-negative case-control study of effectiveness against influenza requiring emergency care in England and serological analysis of primary care patients.
Vaccine
; 42(7): 1656-1664, 2024 Mar 07.
Article
in English
| MEDLINE | ID: mdl-38342716
20.
Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and wales.
Clin Infect Dis
; 56(5): 633-40, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23175560